Abstract
Background
Coronavirus disease of 2019 (COVID-19) has disproportionately affected adults with kidney disease. Data regarding outcomes among children with kidney disease are limited. The North American Pediatric Renal Trials Collaborative Studies Registry (NAPRTCS) has followed children with chronic kidney disease (CKD) since 1987 at 87 participating centers. This study aimed to evaluate the impact of COVID-19 among participants enrolled in the three arms of the registry: CKD, dialysis, and transplant.
Methods
This was a retrospective cohort study of COVID-19 among participants in the NAPRTCS CKD, dialysis, and transplant registries from 2020 to 2022. Where appropriate, t-tests, chi-square analyses, and univariate logistic regression were used to evaluate the data.
Results
The cohort included 1505 NAPRTCS participants with recent data entry; 260 (17%) had documented COVID-19. Infections occurred in all three registry arms, namely, 10% (n = 29) in CKD, 11% (n = 67) in dialysis, and 26% (n = 164) in transplant. The majority of participants (75%) were symptomatic. Hospitalizations occurred in 17% (n = 5) of participants with CKD, 27% (n = 18) maintenance dialysis participants, and 26% (n = 43) of transplant participants. Fourteen percent (n = 4) of CKD participants and 10% (n = 17) of transplant participants developed acute kidney injury (AKI), and a total of eight participants (one CKD, seven transplant) required dialysis initiation. Among transplant participants with moderate to severe illness, 40–43% developed AKI and 29–40% required acute dialysis. There were no reported deaths.
Conclusions
COVID-19 was documented in 17% of active NAPRTCS participants. While there was no documented mortality, the majority of participants were symptomatic, and a quarter required hospitalization.
Graphical abstract
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the authors but restrictions apply to the availability of these data, which were used under agreement with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), and so are not publicly available. Data, however, may be available from the authors upon reasonable request and with permission from NAPRTCS.
References
De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye MM, De Vriese AS, NBVN Kidney Registry Group (2021) Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study. J Am Soc Nephrol 32:385–396
El Karoui K, De Vriese AS (2022) COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. Kidney Int 101:883–894
Ozturk S, Turgutalp K, Arici M, Odabas AR, Altiparmak MR, Aydin Z, Cebeci E, Basturk T, Soypacaci Z, Sahin G, Elif Ozler T, Kara E, Dheir H, Eren N, Suleymanlar G, Islam M, Ogutmen MB, Sengul E, Ayar Y, Dolarslan ME, Bakirdogen S, Safak S, Gungor O, Sahin I, Mentese IB, Merhametsiz O, Oguz EG, Genek DG, Alpay N, Aktas N, Duranay M, Alagoz S, Colak H, Adibelli Z, Pembegul I, Hur E, Azak A, Taymez DG, Tatar E, Kazancioglu R, Oruc A, Yuksel E, Onan E, Turkmen K, Hasbal NB, Gurel A, Yelken B, Sahutoglu T, Gok M, Seyahi N, Sevinc M, Ozkurt S, Sipahi S, Bek SG, Bora F, Demirelli B, Oto OA, Altunoren O, Tuglular SZ, Demir ME, Ayli MD, Huddam B, Tanrisev M, Bozaci I, Gursu M, Bakar B, Tokgoz B, Tonbul HZ, Yildiz A, Sezer S, Ates K (2020) Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant 35:2083–2095
Nikolopoulou GB, Maltezou HC (2022) COVID-19 in children: where do we stand? Arch Med Res 53:1–8
Mastrangelo A, Morello W, Vidal E, Guzzo I, AnnicchiaricoPetruzzelli L, Benetti E, Materassi M, Giordano M, Pasini A, Corrado C, Puccio G, Chimenz R, Pecoraro C, Massella L, Peruzzi L, Montini G, COVID-19 Task Force of the Italian Society of Pediatric Nephrology, COVID-19 TASK FORCE of the Italian Society of Pediatric Nephrology (2021) Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression. Clin J Am Soc Nephrol 16:449–451
Marlais M, Wlodkowski T, Al-Akash S, Ananin P, Bandi VK, Baudouin V, Boyer O, Vasquez L, Govindan S, Hooman N, Ijaz I, Loza R, Melgosa M, Pande N, Pape L, Saha A, Samsonov D, Schreuder MF, Sharma J, Siddiqui S, Sinha R, Stewart H, Tasic V, Tonshoff B, Twombley K, Upadhyay K, Vivarelli M, Weaver DJ, Woroniecki R, Schaefer F, Tullus K (2020) COVID-19 in children treated with immunosuppressive medication for kidney diseases. Arch Dis Child 106:798–801
Talgam-Horshi E, Mozer-Glassberg Y, Waisbourd-Zinman O, Ashkenazi-Hoffnung L, Haskin O, Levi S, Hamdani G, Landau D, Alfandary H (2021) Clinical outcomes and antibody response in COVID-19-positive pediatric solid organ transplant recipients. Pediatr Infect Dis J 40:e514–e516
Singer PS, Sethna C, Molmenti E, Fahmy A, Grodstein E, Castellanos-Reyes L, Fassano J, Teperman L (2021) COVID-19 infection in a pediatric kidney transplant population: a single-center experience. Pediatr Transplant 25:e14018
Bansal N, Ovchinsky N, Foca M, Lamour JM, Kogan-Liberman D, Hsu DT, Beddows K, Abraham L, Coburn M, Cunningham R, Nguyen T, Hayde N (2022) COVID-19 infection in pediatric solid organ transplant patients. Pediatr Transplant 26:e14156
Varnell C Jr, Harshman LA, Smith L, Liu C, Chen S, Al-Akash S, Barletta GM, Belsha C, Brakeman P, Chaudhuri A, Fadakar P, Garro R, Gluck C, Goebel J, Kershaw D, Matossian D, Nailescu C, Patel HP, Pruette C, Ranabothu S, Rodig N, Smith J, Sebestyen VanSickle J, Weng P, Danziger-Isakov L, Hooper DK, Seifert M (2021) COVID-19 in pediatric kidney transplantation: the Improving Renal Outcomes Collaborative. Am J Transplant 21:2740–2748
Goss MB, Galvan NTN, Ruan W, Munoz FM, Brewer ED, O’Mahony CA, Melicoff-Portillo E, Dreyer WJ, Miloh TA, Cigarroa FG, Ranch D, Yoeli D, Adams MA, Koohmaraie S, Harter DM, Rana A, Cotton RT, Carter B, Patel S, Moreno NF, Leung DH, Goss JA (2021) The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multi-organ case series. Pediatr Transplant 25:e13868
Canpolat N, Yildirim ZY, Yildiz N, Tasdemir M, Goknar N, Evrengul H, Gulmez R, Aksu B, Dursun H, Ozcelik G, Yavascan O, Cicek RY, Tulpar S, Hacihamdioglu DO, Nayir A, Alpay H (2022) COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation. Eur J Pediatr 181:117–123
Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11:49–64
Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D (2021) A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health 20:248
Acosta AM, Garg S, Pham H, Whitaker M, Anglin O, O’Halloran A, Milucky J, Patel K, Taylor C, Wortham J, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Reeg L, Kohrman A, Lynfield R, Bye E, Torres S, Salazar-Sanchez Y, Muse A, Barney G, Bennett NM, Bushey S, Billing L, Shiltz E, Sutton M, Abdullah N, Talbot HK, Schaffner W, Ortega J, Price A, Fry AM, Hall A, Kim L, Havers FP (2021) Racial and ethnic disparities in rates of COVID-19-associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March 2020 to February 2021. JAMA Netw Open 4:e2130479
Bruchfeld A (2021) The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol 17:81–82
Chung EYM, Palmer SC, Natale P, Krishnan A, Cooper TE, Saglimbene VM, Ruospo M, Au E, Jayanti S, Liang A, Jie Deng DJ, Chui J, Higgins GY, Tong A, Wong G, Teixeira-Pinto A, Hodson EM, Craig JC, Strippoli GFM (2021) Incidence and outcomes of COVID-19 in people with CKD: a systematic review and meta-analysis. Am J Kidney Dis 78:804–815
CDC (2023) COVID data tracker. US Department of Health and Human Services, Atlanta
Kim L, Whitaker M, O’Halloran A, Kambhampati A, Chai SJ, Reingold A, Armistead I, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Weigel A, Ryan P, Monroe ML, Fox K, Kim S, Lynfield R, Bye E, Shrum Davis S, Smelser C, Barney G, Spina NL, Bennett NM, Felsen CB, Billing LM, Shiltz J, Sutton M, West N, Talbot HK, Schaffner W, Risk I, Price A, Brammer L, Fry AM, Hall AJ, Langley GE, Garg S; COVID-NET Surveillance Team (2020) Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19-COVID-NET, 14 states, March 1–July 25, 2020. MMWR Morb Mortal Wkly Rep 69:1081–1088
Feldman AG, Danziger-Isakov LA (2022) The impact of COVID-19 on the pediatric solid organ transplant population. Semin Pediatr Surg 31:151178
Varnell C Jr, Harshman LA, Liu C, Smith L, Al-Akash S, Barletta GM, Brakeman P, Chaudhuri A, Fadakar P, Galea L, Garro R, Gluck C, Kershaw DB, Matossian D, Patel HP, Peterson C, Pruette C, Ranabothu S, Rodig N, Singer P, Sebestyen VanSickle J, Weng PL, Danziger-Isakov L, Seifert ME, Hooper DK (2023) COVID-19 in pediatric kidney transplantation: a follow-up report of the Improving Renal Outcomes Collaborative. Pediatr Nephrol 38:537–547
Fadel FI, Sabry S, Mawla MAA, Galal REE, Salah DM, Helmy R, Ramadan Y, Elzayat W, Abdelfattah M, Abd Alazem EA (2022) Covid-19 in Egyptian hemodialysis and kidney transplant children: retrospective analysis of single center experience. Ital J Pediatr 48:149
Acknowledgements
We would like to acknowledge the NAPRTCS study group and participants for making this research possible.
North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Principal Investigators
Michael Somers, Boston Children's Hospital
Annabelle Chua, Duke University Medical Center
David Hooper, Cincinnati Children's Hospital Medical Center
Gina-Marie Barletta, Phoenix Children's Hospital
Craig Belsha, Cardinal Glennon Children's Hospital
Paul Brakeman, UCSF Benioff Children's Hospital
Priya Verghese, Lurie Children's Hospital
Meredith Atkinson, Johns Hopkins University
Bradley Warady, Children's Mercy Kansas City
Sharon Bartosh, American Family Madison Wisconsin
Rita Swinford, University of Texas Health Science Center Houston
Rima Zahr, LeBonheur Children's Hospital
Tom Blydt-Hansen, Children's Hospital of British Columbia
Maha Haddad, Univeristy of California Davis
Sarah Kizilbash, University of Minnesota Masonic Children's Hospital
Kathy Lee-Son and Lyndsay Harshman, University of Iowa
Nadine Benador, Rady Children's San Diego
Marissa DeFreitas, University of Miami
Kera Luckritz, University of Michigan
Sahar Fathallah-Shaykh, Children's of Alabama
Jillian Warejko, Yale
Joseph Flynn, Seattle Children's Hospital
Jennifer Jetton, Children's Hospital Wisconsin
Hiren Patel, Nationwide Children's Hospital
Kimberly Czech, University of Illinois
Carl Cramer, Mayo Clinic
Amita Sharma, Massachusetts General Hospital
Vikas Dharnidharka, St. Louis Children's Hospital
Ashton Chen, Wake Forest University
Margret Bock, Children's Hospital of Colorado
Asha Moudgil, Children's National Medical Center
Rachel Milner, Arkansas Children's Hospital
Raoul Nelson, Primary Children's Utah
Kelsey Richardson, Doernbecher Children's Hospital
Marcela Del Rio, The Children's Hospital at Montefiore
Rita Sheth, Loma Linda University Medical Center
Deborah Kees-Folts, Penn State Children's Hospital
Siddarth Shah, Kosair Children's Hospital
Katherine Dell, Cleveland Clinic Children's Hospital
Sarah Swartz, Texas Children's Hospital
Sarah Twichell and Elizabeth Hunt, University of Vermont
Sharon Andreoli, Riley Children's Hospital
Christina Nguyen, Rainbow Babies and Children's Hospital
Dechu Puliyanda, Cedars-Sinai
Benjamin Laskin, Children's Hospital of Philadelphia
Carlos Araya, Nemours Orlando
Scott Sutherland, Stanford
Robert Woroniecki, SUNY Stony Brook
Maury Pinsk, Children's Hospital of Winnipeg
Erin Rademacher, Golisano Children's Hospital at the University of Rochester Medical Center
Diego Aviles, Children's Hospital New Orleans
Syed Kamal, Valley Children's Hospital
Amy Staples, University of New Mexico
Kenneth Lieberman, Hackensack University
Janusz Feber, Children's Hospital of Eastern Ontario
Samhar Al-Akash, Driscoll Children's Kidney Center
Jorge Ramirez, Arnold Palmer
Daniel McKenney, Peyton Manning Children's Hospital at St. Vincent
Alexandru Constantinescu, Joe Dimaggio Children's Hospital
Deogracias Pena, AdventHealth Medical Group Pediatric Nephrology at Orlando
Julia Steinke, Yi Cai, and Jason Thomas, Helen De Vos Children's Hospital
Author information
Authors and Affiliations
Consortia
Contributions
All authors contributed to the study conception and design. Material preparation and data analysis were performed by Sara Boynton and Sarah Twichell. The first draft of the manuscript was written by Sarah Twichell, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This research was approved by the IRBs at the participating centers.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Twichell, S., Ashoor, I., Boynton, S. et al. COVID-19 disease among children and young adults enrolled in the North American Pediatric Renal Trials and Collaborative Studies registry. Pediatr Nephrol 39, 1459–1468 (2024). https://doi.org/10.1007/s00467-023-06241-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-06241-0